Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer

被引:17
|
作者
Chen, Feilong [1 ]
Xiao, Mei [2 ]
Hu, Shaofan [3 ]
Wang, Meng [3 ]
机构
[1] Chengdu Sport Univ, Inst Sports Med & Hlth, Expert Ctr Sichuan Prov, Sports Med Key Lab Sichuan Prov, Chengdu, Peoples R China
[2] Chongqing Univ, Coll Bioengn, Chongqing, Peoples R China
[3] Third Mil Med Univ, Mil Med Univ 3, Dept Biochem & Mol Biol, Chongqing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
基金
中国博士后科学基金;
关键词
Keap1; Nrf2; cancer; structure; function; transcriptional regulation; prevention; clinical; TRANSCRIPTION FACTOR NRF2; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; SIGNALING PATHWAY; ANTIOXIDANT RESPONSE; PROTEASOMAL DEGRADATION; MOLECULAR-MECHANISMS; STRUCTURAL BASIS; LUNG-CANCER; ACTIVATION;
D O I
10.3389/fonc.2024.1381467
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Keap1-Nrf2 signaling pathway is a major regulator of the cytoprotective response, participating in endogenous and exogenous stress caused by ROS (reactive oxygen species). Nrf2 is the core of this pathway. We summarized the literature on Keap1-Nrf2 signaling pathway and summarized the following three aspects: structure, function pathway, and cancer and clinical application status. This signaling pathway is similar to a double-edged sword: on the one hand, Nrf2 activity can protect cells from oxidative and electrophilic stress; on the other hand, increasing Nrf2 activity can enhance the survival and proliferation of cancer cells. Notably, oxidative stress is also considered a marker of cancer in humans. Keap1-Nrf2 signaling pathway, as a typical antioxidant stress pathway, is abnormal in a variety of human malignant tumor diseases (such as lung cancer, liver cancer, and thyroid cancer). In recent years, research on the Keap1-Nrf2 signaling pathway has become increasingly in-depth and detailed. Therefore, it is of great significance for cancer prevention and treatment to explore the molecular mechanism of the occurrence and development of this pathway.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Dysregulation of the Keap1-Nrf2 pathway in cancer
    Leinonen, Hanna M.
    Kansanen, Emilia
    Polonen, Petri
    Heinaniemi, Merja
    Levonen, Anna-Liisa
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2015, 43 : 645 - 649
  • [2] Role of the Keap1-Nrf2 Pathway in Cancer
    Leinonen, Hanna M.
    Kansanen, Emilia
    Polonen, Petri
    Heinaniemi, Merja
    Levonen, Anna-Liisa
    REDOX AND CANCER, PT A, 2014, 122 : 281 - 320
  • [3] The KEAP1-NRF2 pathway: Targets for therapy and role in cancer
    Adinolfi, Simone
    Patinen, Tommi
    Deen, Ashik Jawahar
    Pitkänen, Sini
    Härkönen, Jouni
    Kansanen, Emilia
    Küblbeck, Jenni
    Levonen, Anna-Liisa
    REDOX BIOLOGY, 2023, 63
  • [4] The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
    Kansanen, Emilia
    Kuosmanen, Suvi M.
    Leinonen, Hanna
    Levonen, Anna-Liisa
    REDOX BIOLOGY, 2013, 1 (01): : 45 - 49
  • [5] "Keaping" a lid on lung cancer: the Keap1-Nrf2 pathway
    Best, Sarah A.
    Sutherland, Kate D.
    CELL CYCLE, 2018, 17 (14) : 1696 - 1707
  • [6] The KeAP1-NRF2 System in Cancer
    Taguchi, Keiko
    Yamamoto, Masayuki
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [7] The cytoprotective role of the Keap1-Nrf2 pathway
    Baird, Liam
    Dinkova-Kostova, Albena T.
    ARCHIVES OF TOXICOLOGY, 2011, 85 (04) : 241 - 272
  • [8] KEAP1-NRF2 Pathway as a Modulator of Response to Radiation in Rectal Cancer
    O'Cathail, S. M.
    Lewis, A.
    Hawkins, M. A.
    Maughan, T. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E191 - E192
  • [9] Keap1-Nrf2 pathway and drug resistance in epithelial ovarian cancer
    Zembutsu, Hitoshi
    PHARMACOGENOMICS, 2011, 12 (11) : 1516 - 1517
  • [10] Cancer Chemoprevention Mechanisms Mediated Through the Keap1-Nrf2 Pathway
    Hayes, John D.
    McMahon, Michael
    Chowdhry, Sudhir
    Dinkova-Kostova, Albena T.
    ANTIOXIDANTS & REDOX SIGNALING, 2010, 13 (11) : 1713 - 1748